The 16th Annual CHFR Symposium on Heart Failure was arranged by Center for Heart Failure Research between September 19 and September 21, 2018. The Annual Symposium is an important opportunity for Norwegian scientists to meet with international scientists at the forefront of their field in an informal atmosphere. Below are some pictures from this year’s Symposium, as well as some brief information on the speakers and topics.
Moderated poster sessions was hosted by NORHEART. Pictures and more information about the poster sessions are provided here.
THURSDAY SEPTEMBER 20
OPENING SESSION
ØYSTEIN KRÜGER, South-Eastern Norway Regional Health Authority:
Opening remarks
VALENTIN FUSTER, Icahn School of Medicine at Mount Sinai, New York, NY, USA:
Key note lecture: New frontiers in the cardiovascular field: The science of health
NOVEL APPROACHES TO ASSESSMENT OF RISK AND CARDIAC FUNCTION
NICK L. MILLS, University of Edinburgh, Edinburgh, United Kingdom:
Cardiac troponins beyond the acute coronary syndrome
SATOSHI NAKATANI, Osaka University Graduate Schools of Medicine, Suita, Osaka, Japan:
Novel methods for quantification of left ventricular function
CARDIAC SIGNALING IN PATHOPHYSIOLOGY AND THERAPEUTICS
MANUEL MAYR, King’s College, London, United Kingdom:
A multi-omics approach in the era of precision medicine
DENISE HILFIKER-KLEINER, Hannover Medical School, Hannover, Germany:
An overview of the epidemiology, pathogenesis, and treatment of peripartum cardiomyopathy
FRIDAY SEPTEMBER 21
NEW DEVELOPMENTS IN CARDIAC IMAGING
JARGAT NARULA, Icahn School of Medicine at Mount Sinai, New York, NY, USA:
Imaging atherosclerosis: From precision medicine to population health
THOMAS H. MARWICK, Baker Heart and Diabetes Institute, Melbourne, Australia:
Echocardiographic assessment of left ventricular function for the future – beyond ejection fraction
TRANSLATIONAL PERSPECTIVES ON CARDIAC ELECTROMECHANICAL COUPLING
DAVID A. KASS, The John Hopkins Medical Institution, Baltimore, MD, USA:
PKGing apart heart disease
XANDER H. T. WEHRENS, Baylor College of Medicine, Houston, TX, USA:
Role of abnormal intracellular calcium handling in heart failure pathogenesis
INFLAMMATION IN CARDIAC DISEASE
BRENDAN M. EVERETT, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA:
Inflammation in heart failure: The next therapeutic target?
LUIGI ADAMO, Barnes-Jewish Hospital and Washington University in St Louis, St Louis, MO, USA:
The role of innate immunity in cardiac injury and repair
CARDIOVASCULAR EFFECTS OF EXERCSIE IN HEALTH AND DISEASE
SANJAY SHARMA, St. Georges, University of London, London, United Kingdom:
Exercise: Can ideal therapy become the bitter pill?
(All photos: Anders Revdal, NORHEART)
